Regardless, our results further extend the robustness of previous observations to additional lung cancer cell lines, as we observed that A3A expression provoked particularly strong sensitivity to ATR inhibitors, among the interventions tested (Fig 5A) [32,33]. The gene discussed is ATR; the disease is lung carcinoma.